820 related articles for article (PubMed ID: 29421865)
1. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticulate β-Cyclodextrin with Gallium Tetraphenylporphyrin Demonstrates in Vitro and in Vivo Antimicrobial Efficacy against
Choi SR; Talmon GA; Britigan BE; Narayanasamy P
ACS Infect Dis; 2021 Aug; 7(8):2299-2309. PubMed ID: 34314150
[TBL] [Abstract][Full Text] [Related]
3. Gallium Porphyrin and Gallium Nitrate Synergistically Inhibit
Choi SR; Switzer B; Britigan BE; Narayanasamy P
ACS Infect Dis; 2020 Oct; 6(10):2582-2591. PubMed ID: 32845117
[TBL] [Abstract][Full Text] [Related]
4. Sudapyridine (WX-081) antibacterial activity against
Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
[TBL] [Abstract][Full Text] [Related]
5. Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.
Abdalla MY; Switzer BL; Goss CH; Aitken ML; Singh PK; Britigan BE
Antimicrob Agents Chemother; 2015 Aug; 59(8):4826-34. PubMed ID: 26033732
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of PBTZ169 and pretomanid against Mycobacterium avium,
Zheng L; Qi X; Zhang W; Wang H; Fu L; Wang B; Chen X; Chen X; Lu Y
Front Cell Infect Microbiol; 2023; 13():1115530. PubMed ID: 37077530
[TBL] [Abstract][Full Text] [Related]
7.
Aragaw WW; Cotroneo N; Stokes S; Pucci M; Critchley I; Gengenbacher M; Dick T
Microbiol Spectr; 2022 Feb; 10(1):e0132121. PubMed ID: 35019671
[TBL] [Abstract][Full Text] [Related]
8. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
[No Abstract] [Full Text] [Related]
9. Effective Treatment of Mycobacterium avium subsp. hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal Ciprofloxacin.
Blanchard JD; Elias V; Cipolla D; Gonda I; Bermudez LE
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012773
[TBL] [Abstract][Full Text] [Related]
10.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
11. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
[TBL] [Abstract][Full Text] [Related]
12. Itaconic acid inhibits nontuberculous mycobacterial growth in pH dependent manner while 4-octyl-itaconic acid enhances THP-1 clearance of nontuberculous mycobacteria in vitro.
Breen P; Zimbric M; Caverly LJ
PLoS One; 2024; 19(5):e0303516. PubMed ID: 38728330
[TBL] [Abstract][Full Text] [Related]
13. Indole-2-Carboxamides Are Active against
Pandya AN; Prathipati PK; Hegde P; Li W; Graham KF; Mandal S; Drescher KM; Destache CJ; Ordway D; Jackson M; North EJ
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602519
[TBL] [Abstract][Full Text] [Related]
14. Rifabutin Is Active against Mycobacterium abscessus Complex.
Aziz DB; Low JL; Wu ML; Gengenbacher M; Teo JWP; Dartois V; Dick T
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396540
[TBL] [Abstract][Full Text] [Related]
15. 18 Cases of pulmonary Mycobacterium abscessus: Clinical difference depending on the presence or absence of Mycobacterium avium complex.
Furuta K; Ito A; Ishida T; Ito Y; Sone N; Takaiwa T; Yokoyama T; Tachibana H; Arita M; Hashimoto T
J Infect Chemother; 2016 Sep; 22(9):622-8. PubMed ID: 27430867
[TBL] [Abstract][Full Text] [Related]
16. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
Fröberg G; Maurer FP; Chryssanthou E; Fernström L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyryläinen HL; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schön T;
Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087
[TBL] [Abstract][Full Text] [Related]
17. Thiostrepton: A Novel Therapeutic Drug Candidate for
Kim TH; Hanh BTB; Kim G; Lee DG; Park JW; Lee SE; Kim JS; Kim BS; Ryoo S; Jo EK; Jang J
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835481
[No Abstract] [Full Text] [Related]
18. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
[TBL] [Abstract][Full Text] [Related]
19.
Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
[TBL] [Abstract][Full Text] [Related]
20. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
